Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
February 21, 2024 08:00 ET
|
Route 92 Medical, Inc.
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
Route 92 Medical Announces the 100th Patent for its Neurovascular Intervention Portfolio
January 08, 2024 09:00 ET
|
Route 92 Medical, Inc.
Route 92 Medical announces the receipt of its 100th patent for its rapidly growing portfolio of neuromuscular intervention products.
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
November 16, 2023 09:00 ET
|
Route 92 Medical, Inc.
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
November 14, 2023 09:00 ET
|
Route 92 Medical, Inc.
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
September 18, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Announces Publication of a Retrospective Study in the Interventional Neuroradiology Journal
July 31, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer
July 10, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Receives the First FDA Clearance for a Complete Stroke Treatment System
April 24, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Announces Expansion to New Manufacturing Site in Salt Lake City, Utah
November 16, 2022 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical’s Monopoint® Operating Platform Shows 82% First Pass Effect in Independent Study
July 25, 2022 07:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention,...